| Literature DB >> 28739897 |
Matthew C Surdel1, Dennis J Horvath1, Lisa J Lojek1, Audra R Fullen1, Jocelyn Simpson1, Brendan F Dutter2,3, Kenneth J Salleng1, Jeremy B Ford4, J Logan Jenkins4, Raju Nagarajan5, Pedro L Teixeira6, Matthew Albertolle3,7, Ivelin S Georgiev1,5,8, E Duco Jansen4, Gary A Sulikowski2,3, D Borden Lacy1,4, Harry A Dailey9,10,11, Eric P Skaar12.
Abstract
Gram-positive bacteria cause the majority of skin and soft tissue infections (SSTIs), resulting in the most common reason for clinic visits in the United States. Recently, it was discovered that Gram-positive pathogens use a unique heme biosynthesis pathway, which implicates this pathway as a target for development of antibacterial therapies. We report here the identification of a small-molecule activator of coproporphyrinogen oxidase (CgoX) from Gram-positive bacteria, an enzyme essential for heme biosynthesis. Activation of CgoX induces accumulation of coproporphyrin III and leads to photosensitization of Gram-positive pathogens. In combination with light, CgoX activation reduces bacterial burden in murine models of SSTI. Thus, small-molecule activation of CgoX represents an effective strategy for the development of light-based antimicrobial therapies.Entities:
Keywords: CgoX; antibiotic; bacteria; heme; photosensitization
Mesh:
Substances:
Year: 2017 PMID: 28739897 PMCID: PMC5559000 DOI: 10.1073/pnas.1700469114
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205